Capital Peptides
ARA-290 (Cibinetide) 16mg

Tissue Repair & Recovery · 16mg

ARA-290 (Cibinetide) 16mg

Janoshik-tested · 10 vials per kit

ARA-290 (Cibinetide) – 16mg is a synthetic peptide developed for its neurological and recovery-supportive properties, widely recognized for its potential to support nerve health, inflammatory balance, and overall cellular resilience. Functioning through pathways associated with innate repair receptor activation—particularly mechanisms linked to inflammatory modulation and nerve support—ARA-290 is studied for its ability to support cellular restoration processes. Many users incorporate ARA-290 into their regimen to encourage neurological balance, support recovery pathways, and promote overall wellness resilience.

Research applications

  • Neuroprotection
  • Anti-inflammatory
Read research overview

Choose pack size

$68

AUD · 1 vial

View COAs

≥98%

Purity

Lyophilised

Format

2–3 wks

Arrival

Research Use Only — Disclaimer

This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.